Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Hongbo Hu"'
Autor:
Xiaoqi Han, Siyuan Jiang, Yinmin Gu, Lihua Ding, Enhao Zhao, Dongxing Cao, Xiaodong Wang, Ya Wen, Yongbo Pan, Xin Yan, Liqiang Duan, Minxuan Sun, Tao Zhou, Yajuan Liu, Hongbo Hu, Qinong Ye, Shan Gao
Publikováno v:
Cell Death & Disease. 14
Epithelial-mesenchymal transition (EMT) is associated with the invasive and metastatic phenotypes in colorectal cancer (CRC). However, the mechanisms underlying EMT in CRC are not completely understood. In this study, we find that HUNK inhibits EMT a
Publikováno v:
Frontiers in Oncology. 12
Publikováno v:
Molecular Carcinogenesis. 60:746-757
Programmed death-ligand 1 (PD-L1)-mediated resistance has become a great challenge for tumor treatment. Cisplatin increased tumor PD-L1 expression, promoted chemotherapy resistance. Interferon-γ (IFN-γ)-induced PD-L1 expression might facilitate imm
Publikováno v:
Cancer Science
Increasing bodies of evidence support the involvement of tumor‐intrinsic action in PD‐L1‐mediated cancer progression. However, the mechanisms underlying the tumor‐intrinsic function of PD‐L1 are less well understood. In the present study, w
Autor:
Xuyang Xia, Lunzhi Dai, Yong Peng, Han Luo, Canhua Huang, Maochao Luo, Hongying Zhang, Yang Shu, Hongbo Hu, Zong-Guang Zhou, Yuan Li, Fei Liao, Heng Xu, Minyuan Cao, Xue Liao, Yun Qin, Bo Liu, Li Yang, Wei-Han Zhang, Qiu-Luo Liu, Qianqian Hou, Wei Cheng, Zhinan Xue, Biao Dong, Yuquan Wei, Yan Zhang, Hai-Ning Chen, Wei Zhang, Lie Yang, Xianghui Fu, Zhu Wang, Shouyue Zhang, Jiankun Hu
Publikováno v:
Gut
ObjectiveThe systemic spread of colorectal cancer (CRC) is dominated by the portal system and exhibits diverse patterns of metastasis without systematical genomic investigation. Here, we evaluated the genomic evolution of CRC with multiorgan metastas
Autor:
Kehe Chen, Xianshi Huang, Lei Yu, Jianxun Lu, Fei Huang, Zhiguang Wang, Yan Wei, Encun Hou, Min Luo, Shiqing Huang, Hongbo Hu, Mei Ou
Publikováno v:
Journal of Clinical Oncology. 41:583-583
583 Background: The IMbrave 150 study opened the door of immuno-oncology (IO) combined with targeted therapy in patients (pts) with hepatocellular carcinoma (HCC). At present, some other combination of IO and tyrosine kinase inhibitors (TKIs) had bee
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 345
Cancers, Vol 14, Iss 345, p 345 (2022)
Cancers
Cancers, Vol 14, Iss 345, p 345 (2022)
Cancers
Simple Summary Selenite, a representative inorganic form of selenium, is preferentially accumulated in tumors. The therapeutic potential of sodium selenite in tumors has received significant attention. However, the effect of sodium selenite in the tr
Publikováno v:
Applied Sciences, Vol 11, Iss 10526, p 10526 (2021)
Applied Sciences
Volume 11
Issue 22
Applied Sciences
Volume 11
Issue 22
Gefitinib has been clinically demonstrated to be effective in the first-line setting for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). However, acquired therapeutic resistance to gefitinib almost unavoidably develops, posing
Publikováno v:
Biomedicines
Biomedicines, Vol 9, Iss 1660, p 1660 (2021)
Biomedicines, Vol 9, Iss 1660, p 1660 (2021)
Non-alcoholic fatty liver disease (NAFLD) has become the chronic liver disease with the highest incidence throughout the world, but its pathogenesis has not been fully elucidated. Ferroptosis is a novel form of programmed cell death caused by iron-de
Autor:
Zhinan Xue, Tao Wei, Han Luo, Huairong Tang, Wei Cheng, Yong Jiang, Jihwan Park, Xuyang Xia, Lingyun Zhang, Yan Chen, Yang Liu, Carlos Caulin, Hongbo Hu, Birong Dong, Zhihui Li, Yang Shu, Jingqiang Zhu, Gong Changyang, Ruicen Li, Tian Yang, Heng Xu, Hai-Ning Chen, Shouyue Zhang, Gyeong Dae Kim, Wei-Han Zhang, Lunzhi Dai, Yong Peng, Wei Zhang, Xianghui Fu, Li Yang, Yiguo Hu
Publikováno v:
Science Advances
Clinical staining and targeting CREB3L1 facilitates precise stratification and a potential treatment strategy for thyroid cancer.
Understanding of dedifferentiation, an indicator of poo prognosis for patients with thyroid cancer, has been hamper
Understanding of dedifferentiation, an indicator of poo prognosis for patients with thyroid cancer, has been hamper